{"id":53414,"date":"2023-01-30T15:02:28","date_gmt":"2023-01-30T14:02:28","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/"},"modified":"2023-01-30T15:02:28","modified_gmt":"2023-01-30T14:02:28","slug":"tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/","title":{"rendered":"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum"},"content":{"rendered":"
\n

\nCompany enters 2023 with proven success and market traction; aims to further support healthcare entities and patients tackle affordable healthcare, and expand nation\u2019s largest network<\/i>\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–TailorMed<\/a>, a leading financial navigation technology company that helps patients and healthcare organizations remove financial barriers to care, closed out 2022 with momentum and growth, and an eye towards further progress and market traction in 2023. Last year, the company strengthened its network<\/a> and further developed its best-in-class solutions that enable healthcare entities to proactively identify financially at-risk patients and automate enrollment in vital cost-saving resources.\n<\/p>\n

<\/a><\/p>\n

\nRising healthcare costs and high inflation have deepened affordability challenges<\/a> for patients and the entire health system. TailorMed\u2019s network-driven, technology-powered approach offers a comprehensive solution by uniting all impacted parties with the same goal: to ensure all <\/i>patients across all medical conditions can afford care. In 2022, the company expanded its network \u2013 already the nation’s largest \u2013 with the addition of new providers, pharmacies, life science companies, and other partners. TailorMed\u2019s solutions have now been implemented across more than 500 hospitals, 1,000-plus clinics, nearly 600 pharmacies, five life science companies, and 65 brands. Its network includes more than 133,000 physicians and over 13.5 million patients, who account for more than 87 million prescriptions.\n<\/p>\n

\nWith patients at the heart of its mission, TailorMed secured $1.75 billion in patient funding in 2022 \u2013 from resources ranging from drugmaker copay assistance to charitable funds. This brings the cumulative value of patient funding secured since the company\u2019s founding in 2016 to over $2.9 billion. TailorMed\u2019s reach now spans more than 6,000 assistance programs, covering more than 1,000 chronic conditions. In fact, the company\u2019s commitment to purpose-driven innovation was recognized<\/a> by the 2022 UCSF Digital Health Awards. Selected from hundreds of companies, TailorMed was named a best-in-class finalist in the Patient Cost Savings category.\n<\/p>\n

\nIn 2022, TailorMed also focused on empowering patients and meeting healthcare consumers\u2019 growing demand for more seamless, user-friendly financial experiences. The company looks forward to continued progress toward this and other initiatives in 2023.\n<\/p>\n

\n\u201cI\u2019m incredibly proud that 2022 was such a landmark year for the company,\u201d said Srulik Dvorsky, CEO and Co-Founder of TailorMed. \u201cWe are energized by our accomplishments and look forward to building on last year\u2019s momentum as we enter 2023. Our success overall \u2013 including the expansion of our network, technology advancements, and award wins \u2013 is a testament to the value we provide to both healthcare organizations and patients alike. As the healthcare industry continues to evolve in 2023 and beyond, we are well-positioned to make an even bigger impact and to realize our vision of affordable care for all.\u201d\n<\/p>\n

\nTo learn more about TailorMed\u2019s advancements in the last year, please visit: https:\/\/tailormed.co\/2022-year-in-review\/<\/a>. For more information on the company\u2019s platform and to see if it might benefit your healthcare entity, please visit: https:\/\/tailormed.co\/platform\/<\/a>.\n<\/p>\n

\nAbout TailorMed:<\/b>\n<\/p>\n

\nTailorMed offers the nation\u2019s largest network of patients, providers, pharmacies, partners, and life science companies focused on ensuring all patients across all medical conditions can afford treatment. Driven by TailorMed’s best-in-class platform, network constituents can proactively identify, match, and enroll patients in financial assistance programs to deliver a world-class patient financial experience while reducing the cost of care delivery and increasing revenues. TailorMed\u2019s secure, web-based financial assistance solutions are deployed across more than 1,000 sites of care, including Providence Health, UnityPoint Health, Yale-New Haven Health, and Advocate Aurora Health. To learn more, go to tailormed.co<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia:<\/b>
Angelica English, TailorMed@pancomm.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company enters 2023 with proven success and market traction; aims to further support healthcare entities and patients tackle affordable healthcare, and expand nation\u2019s largest network NEW YORK–(BUSINESS WIRE)–TailorMed, a leading financial navigation technology company that helps patients and healthcare organizations remove financial barriers to care, closed out 2022 with momentum and growth, and an eye … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53414","6":"format-standard","7":"category-industry"},"yoast_head":"\nTailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company enters 2023 with proven success and market traction; aims to further support healthcare entities and patients tackle affordable healthcare, and expand nation\u2019s largest network NEW YORK–(BUSINESS WIRE)–TailorMed, a leading financial navigation technology company that helps patients and healthcare organizations remove financial barriers to care, closed out 2022 with momentum and growth, and an eye ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-30T14:02:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230130005061\/en\/1698448\/21\/TailorMed-Logo-navy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum\",\"datePublished\":\"2023-01-30T14:02:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/\"},\"wordCount\":582,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005061\\\/en\\\/1698448\\\/21\\\/TailorMed-Logo-navy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/\",\"name\":\"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005061\\\/en\\\/1698448\\\/21\\\/TailorMed-Logo-navy.jpg\",\"datePublished\":\"2023-01-30T14:02:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005061\\\/en\\\/1698448\\\/21\\\/TailorMed-Logo-navy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230130005061\\\/en\\\/1698448\\\/21\\\/TailorMed-Logo-navy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/","og_locale":"en_US","og_type":"article","og_title":"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum - Pharma Trend","og_description":"Company enters 2023 with proven success and market traction; aims to further support healthcare entities and patients tackle affordable healthcare, and expand nation\u2019s largest network NEW YORK–(BUSINESS WIRE)–TailorMed, a leading financial navigation technology company that helps patients and healthcare organizations remove financial barriers to care, closed out 2022 with momentum and growth, and an eye ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-30T14:02:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230130005061\/en\/1698448\/21\/TailorMed-Logo-navy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum","datePublished":"2023-01-30T14:02:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/"},"wordCount":582,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005061\/en\/1698448\/21\/TailorMed-Logo-navy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/","url":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/","name":"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230130005061\/en\/1698448\/21\/TailorMed-Logo-navy.jpg","datePublished":"2023-01-30T14:02:28+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230130005061\/en\/1698448\/21\/TailorMed-Logo-navy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230130005061\/en\/1698448\/21\/TailorMed-Logo-navy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/tailormed-deepens-commitment-to-healthcare-affordability-closes-2022-with-demonstrated-growth-and-momentum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"TailorMed Deepens Commitment to Healthcare Affordability, Closes 2022 with Demonstrated Growth and Momentum"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53414"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53414\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}